Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icaritin in Advanced Hepatocellular Carcinoma
NCT01972672Phase 2Completed
- Start
- Oct 2013
- Primary completion
- Aug 2015
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Icaritin in hepatocellular carcinoma (HCC). Started Oct 2013; status: completed.
02
Drugs
Icaritin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01972672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01972672.